Close

BIO 2000 Program Provides Teachers Update On Biotechnology

Mar 23 2000
WASHINGTON, D.C. (March 23, 2000) More than 100 teachers from 23 states and Canada will take part in the Teacher Professional Development Program at BIO 2000, March 26-30, in Boston.

The three...

BIO Files Comments On Proposed Guidelines From PTO For Patenting Gene-Based Inventions

Mar 22 2000
WASHINGTON, D.C. (March 22, 2000) The Biotechnology Industry Organization (BIO) today filed comments with the U.S. Patent and Trademark Office (PTO) on its proposed guidelines and training manual...

People Battling Illnesses, Injuries Discuss Personal Experiences At BIO 2000

Mar 22 2000
WASHINGTON, DC (March 22, 2000) People benefiting from innovative biotechnology treatments against such diseases as rheumatoid arthritis, multiple sclerosis and Gaucher disease will discuss their...

BIO 2000 Speakers Discuss Human Genome Project, Agricultural Biotech In Developing Nations

Mar 17 2000
WASHINGTON, D.C. (March 17, 2000) Featured speakers at BIO 2000's lunch Wednesday, March 29, will discuss a variety of topics, including the risks and benefits of agricultural biotechnology in...

Backgrounder On Patenting Gene-Based Inventions

Mar 16 2000

...

BIO 2000 Attracts Record International Contingent

Mar 14 2000
Washington, D.C., (March 14, 2000) -- BIO 2000 in Boston, March 26-30, will include the largest international contingent ever assembled for the annual conference of the Biotechnology Industry...

BIO Responds To Clinton, Blair Statement On Gene-Based Health-Care Research

Mar 14 2000
WASHINGTON, DC (March 14, 2000) The Biotechnology Industry Organization (BIO) issued the following response to the statement made today by President Bill Clinton and British Prime Minister Tony...

BIO Testifies In Support Of Gene Therapy Trials

Mar 10 2000
WASHINGTON, D.C. (March 10, 2000) The Biotechnology Industry Organization (BIO) applauded the National Institutes of Health Recombinant DNA Advisory Committee (RAC) for its decision today to...

Maine Price Controls Will Stifle Biotech Innovation

Mar 8 2000
WASHINGTON, D.C. (March 8, 2000) Nancy Myers, health care policy and reimbursement counsel of the Biotechnology Industry Organization (BIO), issued the following statement concerning legislation...

BIO 2000 Science Presentations Feature Latest Research Breakthroughs

Mar 7 2000
WASHINGTON, D.C. (March 7, 2000) BIO 2000 in Boston, March 26-30, will feature four days of scientific presentations examining the latest research on a variety of life-threatening diseases and...